Researchers Identify Cause of Muscle Pain Linked to Statins

A recent study from the Columbia University Irving Medical Center has uncovered a potential explanation for the muscle pain that many patients experience while taking statins, a widely prescribed class of cholesterol-lowering medications. Researchers found that certain statins, particularly simvastatin, can bind to a key protein in muscle cells, resulting in a detrimental leak of calcium ions. This discovery may shed light on why approximately 10 percent of patients discontinue statin therapy due to muscle-related side effects.

Muscle pain and weakness are among the most common reasons patients stop taking statins, which are prescribed to around 40 million adults in the United States. The findings, published on December 15, 2025, in the Journal of Clinical Investigation, suggest that the calcium leak induced by statin interaction could directly weaken muscle fibers or activate enzymes that gradually deteriorate muscle tissue.

Understanding the Mechanism Behind Statin Side Effects

For decades, scientists have been puzzled by the muscular side effects associated with statins since the drugs were introduced in the late 1980s. While these medications effectively lower cholesterol by inhibiting an enzyme involved in its production, they can also interact with unintended targets in the body. Previous research indicated a potential link between statin use and specific muscle proteins, but the precise mechanisms remained elusive.

Utilizing advanced imaging techniques, specifically cryo-electron microscopy, the team at Columbia was able to visualize how simvastatin interacts with muscle cells. The images revealed that the drug attaches to two distinct sites on the ryanodine receptor, a crucial protein for muscle function. This binding opens a channel within the receptor, allowing calcium to escape into regions of the cell where it is not typically found.

According to Andrew Marks, chair of the Department of Physiology and Cellular Biophysics at the Vagelos College of Physicians and Surgeons, while this mechanism may not apply to every individual experiencing side effects, it could significantly impact a considerable number of patients. “Even if it explains a small subset, that’s a lot of people we could help if we can resolve the issue,” Marks stated.

Potential Solutions and Future Directions

The implications of this research extend beyond understanding the side effects of statins. The findings open the door to developing safer cholesterol-lowering medications. One promising approach involves redesigning statins to retain their cholesterol-lowering properties without binding to the ryanodine receptor in muscle cells. Marks is collaborating with chemists to create these modified statins.

Additionally, the research team has identified a potential method to prevent the calcium leak itself. Experimental drugs developed in Marks’ laboratory could close the calcium leaks observed in animal models. “These drugs are currently being tested in people with rare muscle diseases. If they prove effective in those patients, we can explore their use in statin-induced myopathies,” Marks explained.

The study has garnered support from multiple grants from the National Institutes of Health (NIH), reflecting its significance in addressing a widespread issue in cardiovascular health. As researchers continue to investigate these findings, the hope is to provide solutions that will allow patients to benefit from statins without the burden of painful side effects.

In conclusion, the discovery of how certain statins interact with muscle proteins marks a significant advancement in understanding muscle pain associated with these medications. Ongoing research aims to develop strategies that could help millions of patients manage their cholesterol effectively while minimizing adverse effects.